Basilea Pharmaceutica

This study is testing whether a new medication called fosmanogepix works as well as current standard treatments for serious Candida fungal infections in the blood or organs. About 450 adults with these life-threatening infections will receive either the new treatment or standard …

This study is testing a new drug called fosmanogepix for adults with severe, invasive mold infections that are often resistant to other treatments. It will compare the new drug to standard antifungal care for some patients and use it as a rescue therapy for others who haven't res…

This is the first study in people for a new antibiotic called BAL2420, which is being developed to fight serious bacterial infections. Researchers are testing it in healthy volunteers to see if it is safe, how well it is tolerated, and how the body processes it. The study will gi…

This early-stage study aims to check the safety and measure how the body processes a new combination antibiotic drug. Researchers will enroll 46 healthy adults to receive the medication and monitor them for side effects. The study focuses on understanding how the drug moves throu…